Biotech Stock 365% This: Big Bet on 3-NDA Strategy
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesA focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Starbucks still faces investor headwinds as revenue grows slowly and profitability remains pressured. A closer look a...
A Florida widow has filed a federal lawsuit against OpenAI, alleging ChatGPT helped plan a mass shooting at Florida S...
Intuit stock has faced a tough spell, but the business remains resilient. This guide breaks down why intuit stock ove...
Bitcoin slipped as renewed U.S. strikes on Iran sparked fresh volatility. Analysts warn that the fate of the peace ta...
As the FVRA clock nears its 210-day limit, questions emerge over Vought’s authority guiding the CFPB. The agency has ...
Oil prices reined in around $97 per barrel on June 8, 2026, with Brent signaling a cautious balance between supply ri...
Microsoft rolled out a fresh coding AI family at Build, aiming to accelerate developer tooling. Investors will watch ...
Altura announces a controlled wind-down of its stablecoin vault after a surge in redemptions, underscoring liquidity ...
Micron Technology stunned investors with an earnings beat and an ultra-high gross margin, suggesting it is riding an ...
The Strategic Petroleum Reserve sits at a 43-year low as ongoing releases continue to drain stocks, prompting questio...